Expression of TGF-β1 and Smad4 in oxygen-induced retinopathy in neonatal mice

Chuntao Lei,Xiaoqi Zhang,Yingchuan Fan,Xuedong Zhang,Jie Zhong,Jianbin Hu
DOI: https://doi.org/10.3760/cma.j.issn.2095-0160.2006.05.020
2006-01-01
Abstract:Objective: TGF-β has been proven to have multiple biologic functions, and researchers are paying more attention to its role in the induction of neovascularization. The present paper investigated the expression of TGF-β1 and Smad4-mRNA in oxygen-induced retinopathy in neonatal mice. Methods: Ten one-week-old mice were exposed to 75% oxygen for 5 days and then to room air. Another group of 10 one-week-old mice exposed to room air served as control. All animals were killed on post-natal day 17 and both eyes were enucleated. The active neovascular response was evaluated by counting endothelial cell nuclei of new vessels on the internal limiting membrane and the data were analyzed with special software. The expression of retina TGF-β1 was detected with immunocytochemistry and Smad4-mRNA expression by in situ hybridization (ISH). Results: About 22 ± 3.5 neovascular nuclei per cross-section were seen in the oxygen-treated group and less than 1 nuclei in the control group (P < 0.01). Brown particle was seen in the internal limiting membrane, showing a positive expression of TGF-β1 and Smad4-mRNA, and expression of retinal TGF-β1 was stronger in the oxygen-treated group than in the control group. Expression of TGF-β1 and Smad4-mRNA with IH assay in retina of oxygen-treated mice were significantly stronger than control group. Conclusion: Expression of TGF-β1 and Smad4 is upregulated in the oxygen-induced retinopathy. TGF-β/Smad may take part in the neovascularization in retina. TGF-β signal pathway may be a new target for prevention and treatment of neovascularization.
What problem does this paper attempt to address?